
Progyny (PGNY) Stock Forecast & Price Target
Progyny (PGNY) Analyst Ratings
Bulls say
Progyny is a fertility benefits management company that offers a wide range of fertility and family building benefits solutions to clients across various industries. The company has a strong track record of client retention and has been able to maintain a high level of revenue growth through expansion into new products and services. Additionally, Progyny is well-positioned to continue gaining market share and expanding internationally, making it a promising investment opportunity with strong fundamentals and a positive outlook for the future.
Bears say
Progyny is experiencing declining overall revenue per ART cycle, a potential red flag as it suggests declining demand or increased competition in the fertility market. Additionally, the company's newer offerings are currently included in medical revenue, which can potentially distort the medical revenue per ART cycle calculation. Furthermore, while the company reports strong financials, its stock faces potential volatility due to investor concerns about the impact of unemployment on client retention and sales.
This aggregate rating is based on analysts' research of Progyny and is not a guaranteed prediction by Public.com or investment advice.
Progyny (PGNY) Analyst Forecast & Price Prediction
Start investing in Progyny (PGNY)
Order type
Buy in
Order amount
Est. shares
0 shares